期刊文献+

TGF-β1基因真核表达载体的构建及在BMSCs中的表达 被引量:8

CONSTRUCTION OF EUKARYOTIC VECTOR CARRYING TGF-β1 GENE AND ITS EXPRESSION IN BONE MESENCHYMAL STEM CELLS
下载PDF
导出
摘要 目的 研究真核表达载体pCDNA3 .1 (+) TGF- β1 在骨髓间充质干细胞(BMSCs) 中的表达。方法 基因克隆构建pCDNA3 .1 (+) TGF- β1 真核表达载体, 转染大鼠BMSCs, G418 筛选获得稳定转染的细胞, RT- PCR、ELISA和免疫细胞化学检测其表达, MTT 法检测其增殖活性。结果 成功构建含TGF- β1 基因的真核表达载体; RT- PCR、ELISA、免疫细胞化学证实了TGF- β1基因在BMSCs中至少可以表达一个月; MTT法提示转染TGF- β1基因可以促进BMSCs增殖。结论 pCDNA3. 1 (+) TGF -β1转染BMSCs可获得稳定表达。 Objective To construct the eukaryotic vector containing TGF-β1, which was transfected intobone mesenchymal stem cells and expressed. Methods Plasmid pCDNA3.1(+) containing human transforming growth factor β1 gene was constructed and then transfected into the primary cultured rBMSCs under the mediation of Lipofectamine. Positive clones were selected by G418; the expression was verifiedby using RT-PCR, ELISA, and immunocytochemical staining; and the proliferation of the transfected BMSCs was evaluated by MTT. Results RT-PCR, ELISA and immounhistochemical staining of post-transgenic BMSCs were TGF-β1positive. MTT colorimetric methodshowed that the transfected TGF-β1 had a positiveeffect on the proliferationof BMSCs. Conclusion Transfection ofpCDNA3.1(+)-TGF-β1can provide persistent expression in BMSCs.
出处 《中国组织化学与细胞化学杂志》 CAS CSCD 2005年第2期217-221,共5页 Chinese Journal of Histochemistry and Cytochemistry
基金 武汉市科技攻关计划项目 (20036004)
关键词 骨髓间充质干细胞 转化生长因子Β1 基因转染 Bone mesenchymal stem cell(BMSC) Gene transfection Transforming growth factor-β1
  • 相关文献

参考文献10

  • 1Kandziora F, Schmidmaier G, Schollmeier G, et al. IGF-I and TGF-beta1 application by a poly-(D,L-lactide)-coated cage promotes intervertebral bone matrix formation in the sheep cervical spine. Spine,2002 ,27(16):1710-1723.
  • 2Theresa L. Inhibition of growth and differentiation of osteoprogenitors in mouse bone marrow stromal cell cultures by increased donor age and glucocorticoid treatment. Bone,2004 ,35(1): 83-95.
  • 3Itoh S, Matubara M, Kawauchi T, et al.Enhancement of bone ingrowth in a titanium fiber mesh implant by rhBMP-2 and hyaluronic acid.J Mater Sci Mater Med, 2001, 12(7):575-581.
  • 4Sykaras N, Triplett RG, Nunn ME, et al. Effect of recombinant human bone morphogenetic protein-2 on bone regeneration and osseointegration of dental implants.Clin Oral Implants Res, 2001,12(4):339-349.
  • 5Blom EJ, Klein-Nulend J, Yin L, et al. Transforming growth factor-beta1 incorporated in calcium phosphate cement stimulates osteotransductivity in rat calvarial bone defects. Clin Oral Implants Res,2001,12(6):609-616.
  • 6Horwood NJ, Smith C, Andreakos E, et al. High-efficiency gene transfer into nontransformed cells: utility for studying gene regulation and analysis of potential therapeutic targets.Arthritis Res,2002, Suppl 3:S215-225.
  • 7Otto WR, Rao J. Tomorrow's skeleton staff: mesenchymal stem cells and the repair of bone and cartilage. Cell Prolif,2004 ,37(1):97-110.
  • 8Sato N, Nakayama M, Arai K. Fluctuation of chromatin unfolding associated with variation in the level of gene expression. Genes Cells,2004,9(7):619-630.
  • 9Mosmann T. Rapid colorimetic assay for celluar growth and survival:Applicationto proliferation and cytotoxicity assay. J Immunol Methods,1983,65:55-63.
  • 10Ber R, Kubota T, Sodek J,et al. Effects of transforming growth factor-beta on noumal clone bone cell population. Biochem Cell Boil,1991,69(1):132-140.

同被引文献95

引证文献8

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部